Search
BioLife Solutions Inc
BLFSAdd to Watchlist
31.280USD
-0.360-1.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.53BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of BioLife Solutions Inc is 8.44, ranking 36 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 32.00, with a high of 34.00 and a low of 30.00.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
31.125
Target Price
-0.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
BioLife Solutions Inc
BLFS
9
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is BioLife Solutions Inc's expected revenue for the next quarter?
BioLife Solutions Inc's expected revenue is 27.68M.
What is BioLife Solutions Inc's price target?
Analysts forecast that BioLife Solutions Inc's price target is USD 32.00, with the highest forecast at USD 34.00 and the lowest forecast at USD 30.00.
How have BioLife Solutions IncBLFS's recent earnings per share performed?
The market expectation was USD 0.02, while BioLife Solutions IncBLFS's earnings per share (EPS) for the previous quarter was USD 0.23. EPS for the next quarter is expected at USD 0.03.
What is the analyst rating for BioLife Solutions Inc?
Based on the ratings of BioLife Solutions Inc's stock from 9 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.